Prospects and Challenges of Generic Medicines Adoption in India: Consumer and Physician Perspectives
Pharmaceutical Science-Pharma
DOI:
https://doi.org/10.22376/ijpbs/lpr.2022.12.5.P51-60Keywords:
Generic Medicines, Healthcare, Pharmaceutical, Physicians, IndiaAbstract
The objective of this study was to learn more about consumers’ and physicians’ knowledge, attitudes, and beliefs about generic medicines, as well as the problems in guaranteeing generic medicine acceptance and utilization. The aim of our study was to figure out what would improve physician acceptance and customer acceptance. The study included qualitative research with focus group conversations with physicians from various fields of medicine, as well as a cross-sectional survey with 102 customers in Pune divided into two clusters utilizing a questionnaire. An exploratory factor analysis was performed to see if there were any differences between the components, that support favorable opinions of Generic Medicines and those that support negative perceptions of the same. Customers were positive, about the usage of generic drugs according to the findings. The findings showed a preference to use them on doctor’s prescriptions and Government or other regulatory agencies approval. Physicians also proposed that the government should make it mandatory for generic medicines to be prescribed by doctors and launch a robust public awareness campaign to encourage their use in India. There was an acceptance that, using generic medicine would significantly lower healthcare expenses. The physicians believed that generic bioavailability and bioequivalence were important factors to consider when deciding whether or not to prescribe generics. Clinical trial data and serious adverse event (SAE) data, should also be made available to the medical community so that transparent and independent decisions can be made.
References
Warier, N. and Mehta, P., 2016. Comparative Study of Generic Drug Registration Requirements for Dossier Submission in African Region-Kenya, Ghana, Nigeria, and Botswana. Applied Clinical Research, Clinical Trials and Regulatory Affairs, 3(2), pp.71-81.
Bhargava A, Kalantri S P. The crisis in access to essential medicines in India: key issues which call for action. Ind J of Med Ethics. 2013 April-June 10 (2): 86-95.
van Doorslaer E, O’Donnell O, Rannan-Eliya RP, Somanathan A, Adhikari SR, Garg CC, Harbianto D,Herrin AN,Huq MN, Ibragimova S, Karan A,Ng C, Pande BR, Racelis R,Tao S,Tin K,Tisayaticom K,Trisnantoro L,Vasavid C, Zhao Y. Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey data. Lancet. 2006 Oct 14;368 (9544):1357-64.
Shahrawat R, Rao KD. Insured yet vulnerable: out-of-pocket payments and India’s poor. Health Policy Plan. 2012 May;27(3):213-21.
Pareek, M. and Prakash, M., 2019. Providing generic medicines to the poor in India: An overall assessment of government-run generic medicine scheme Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) with reference to the experience of store owners in the city of Jaipur. International Journal of Pharmaceutical Research, [online] 11(02), pp.32-37.
Tatham A J. The Use of Generic Medications for Glaucoma. J of Ophthalmology. 2020. https://doi.org/10.1155/2020/1651265.
Joshi, S. S., Shetty, Y. C., and Karande, S. (2019). Generic drugs - The Indian scenario. Journal of postgraduate medicine, 65(2), 67–69. https://doi.org/10.4103/jpgm.JPGM_420_18
Aivalli P K, Elias M A, Pati M K, Bhanuprakash S, Munegowda C, Shroff Z C, Srinivas P N. Perceptions of the quality of generic medicines: implications for trust in public services within the local health system in Tumkur, India. BMJ Glob Health 2018; 2: e000644. doi:10.1136/bmjgh-2017-000644.
Mathew P. Generic drugs: Review and experiences from South India. J Family Med Prim Care. 2015 Jul-Sep; 4(3): 319–323.
Rana P, Roy V. Generic medicines: issues and relevance for global health. Fundam Clin Pharmacol. 2015 Dec; 29(6): 529-42.doi: 10.1111/fcp.12155.
McMullana P, Vamadevan S A, Srinivas R, Bhallad S, Prabhakaran D, Banerjee A. Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis. GLOBAL HEALTH ACTION, 2018. 11, 1434935. https://doi.org/10.1080/16549716.2018.1434935.
Gupta R, Malhotra A, Malhotra P. A study on assessment of awareness on generic drugs among doctors in a tertiary care teaching hospital in north India. Int J Res Med Sci. 2018 Apr; 6(4):1362-1367.
Hebbar SK, Nalini GK, Deepak P, Sahana GN, Nagaral JV. Assessment of awareness on generic drugs among health care professionals and laypersons. Int J Basic Clin Pharmacol 2017;6 (3): 680-3.
Jamshed S Q, Hassalli M A A, Ibrahim M I M, Babar Z. Knowledge attitude and perception of dispensing doctors regarding generic medicines in Karachi, Pakistan: A qualitative study.J Pak Med Assoc. 2011. Jan 61 (1): 80 - 83.
Rana P., Roy V. Generic Medicines: issues and relevance for global health. Fundam. Clin. Pharmacol. (2015) 29 529–542.
Le Jeunne, C. (2015). Generics, are we there yet? Fundamental and Clinical Pharmacology, 29(6), 521–521. doi:10.1111/fcp.12164
Drozdowska A., Hermanowski T. Solution-driven approaches togeneric substitution challenges - a survey among internationalexperts. Fundam. Clin. Pharmacol. (2015) 29 529–603
Colgan, S., Faasse, K., Martin, L.R., Stephens, M.H., Grey, A. and Petrie, K.J. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open 5, e008915 (2015).
Yu, Y., and Maliepaard, M. (2018). Interchangeability of Generics-Experiences and Outlook Toward Pharmacokinetics Variability and Generic-Generic Substitution. Clinical Pharmacology and Therapeutics. doi:10.1002/cpt.1250 .
Le Jeunne C. (2015). Generics, are we there yet? Fundamental and clinical pharmacology, 29(6), 521. https://doi.org/10.1111/fcp.12164
Drozdowska, A., and Hermanowski, T. (2015). Solution-driven approaches to generic substitution challenges - a survey among international experts. Fundamental and clinical pharmacology, 29(6), 592–603. https://doi.org/10.1111/fcp.12139
Toverud, E. L., Hartmann, K., and Håkonsen, H. (2015). A Systematic Review of Physicians' and Pharmacists' Perspectives on Generic Drug Use: What are the Global Challenges?. Applied health economics and health policy, 13 Suppl 1(Suppl 1), S35–S45. https://doi.org/10.1007/s40258-014-0145-2
Hassali, M. A., Wong, Z. Y., Alrasheedy, A. A., Saleem, F., Mohamad Yahaya, A. H., and Aljadhey, H. (2014). Perspectives of physicians practicing in low and middle income countries towards generic medicines: a narrative review. Health policy (Amsterdam,Netherlands), 117(3),297–310. https://doi.org/10.1016/j.healthpol.2014.07.014
Colgan, S., Faasse, K., Martin, L. R., Stephens, M. H., Grey, A., and Petrie, K. J. (2015). Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ open, 5(12), e008915. https://doi.org/10.1136/bmjopen-2015-008915
Fadare, J. O., Adeoti, A. O., Desalu, O. O., Enwere, O. O., Makusidi, A. M., Ogunleye, O., Sunmonu, T. A., Truter, I., Akunne, O. O., and Godman, B. (2016). The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert review of pharmacoeconomics and outcomes research, 16(5), 639–650.
Zhao, M., Zhang, L., Feng, Z., and Fang, Y. (2021). Physicians' Knowledge, Attitude and Practice of Generic Substitution in China: A Cross-Sectional Online Survey. International journal of environmental research and public health, 18(15), 7749. https://doi.org/10.3390/ijerph18157749
Gupta S.K., Nayak R.P., Vidyarthi S.K.(2015) A study on the knowledge, attitude, and practice of generic medicines among the doctors in a tertiary care teaching hospital in South India. Natl. J. Physiol. Pharm. Pharmacol. 2015; 5:39–44. doi: 10.5455/njppp.2015.5.170720141.
Cook A. How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry. Washington DC: The Congress of the United States, Congressional Budget Office; 1998. Available from: 〈http://www.cbo.gov/sites/default/files/cbofiles/ftpdocs/6xx/doc655/pharm.pdf
Levinson DR. Medicare overpaid on drugs with new generics. Office of inspector general report; 2008. 14. Fein A. Generic drugprofits: too high or appropriate incentive? Gerson Lehrman Group News; September 11, 2008.
The Health Strategies Consultancy LLC. Follow the pill: understanding the U.S. commercial pharmaceutical supply chain. Menlo Park, CA: The Kaiser Family Foundation; 2005 Available from: 〈http://www.kff.org/rxdrugs/upload/follow-the-pill-understanding-the-u-s-commercial-pharmaceutical-supply-chain-report.pdf〉.
Ellison SF, Snyder CM. Countervailing power in wholesale pharmaceuticals. J Ind Econ 2010; 58:32–53. 17. Mulligan C. The generic drug scandal. New York
Desai S., Dass A.P., Kaniganti S. Assessment of perception and attitude of postgraduates and clinicians toward generic versus branded medicines at a teaching medical institute. Natl. J. Physiol. Pharm. Pharmacol. 2018; 8:540–543. doi: 10.5455/njppp.2018.8.1144523112017
Lavanya D., Dhivya K., Deekshitha P., Pravallika S., Kesini M. Attitude towards generic formulations usage: Narrowing the gap between pharmacist and physicians. Int. J. Pharm. Pharm. Sci. 2019; 11:117.
Mathew P. (2015). Generic drugs: Review and experiences from South India. Journal of family medicine and primary care, 4(3), 319–323. https://doi.org/10.4103/2249-4863.161305
Published
How to Cite
Issue
Section
Copyright (c) 2022 Abhijit Chattoraj, Manoj Pareek, Becky Thomas, Steward Doss
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
